Monopolar Current Cutting Knife vs Bipolar RFA Knife

Sponsor
Baylor College of Medicine (Other)
Overall Status
Recruiting
CT.gov ID
NCT04919824
Collaborator
(none)
88
2
2
14.8
44
3

Study Details

Study Description

Brief Summary

This is a prospective, randomized trial that aims to study the efficacy and clinical outcomes of Creo Medical's novel Bipolar RS2 Speedboat Knife vs. Monopolar Knives on patients who undergo endoscopic submucosal dissection (ESD) procedure at Baylor St. Luke's Medical Center.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Endoscopic Submucosal Dissection
  • Procedure: Endoscopic Mucosal Resection
N/A

Detailed Description

Endoscopic submucosal dissection (ESD) is a novel technique for the removal of advanced colonic polyps with high-risk features. ESD is minimally invasive and allows the removal of colonic adenomatous polyp without resorting to surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.

Traditionally, knifes utilizing monopolar current such as dual knife or hybrid knife were the preferred tools for endoscopic submucosal dissection. These knifes allows accurate dissection and excellent hemostasis. However, due to monopolar current generated heat, post coagulation syndrome can be seen in up to 8 to 40 % of patients. Post coagulation syndrome present with abdominal pain, fever and leukocytosis and requires supportive treatment with IV fluid and antibiotics. Recently, a novel bipolar Radiofrequency Ablation (RFA) knife were approved by FDA for the performance of ESD. The knife utilizes bipolar RFA current for submucosal dissection which can potentially expedite submucosal dissection and decrease the rates of post polypectomy syndrome.

Our tertiary referral center Baylor St Luke's Medical Center is center of excellence for ESD procedure and we have previously reported our ESD experience using specialized stability and traction device and monopolar current knife in 111 patients. The goal of our protocol is to compare the performance of monopolar current cutting knife and bipolar RFA knife in colonic endoscopic submucosal dissection.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
88 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Comparison of the Performance of Monopolar Current Cutting Knife and Bipolar RFA Knife in Colonic Endoscopic Submucosal Dissection
Actual Study Start Date :
Jan 5, 2022
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Bipolar Knife

ESD procedure performed with Creo Medical Speedboat RS2.

Procedure: Endoscopic Submucosal Dissection
Endoscopic submucosal dissection (ESD) is a novel technique for the removal of advanced colonic polyps with high-risk features. ESD is minimally invasive and allows the removal of colonic adenomatous polyp without resorting to surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.
Other Names:
  • ESD
  • Procedure: Endoscopic Mucosal Resection
    Endoscopic mucosal resection (EMR) is a conventional endoscopic technique commonly used for the resection of superficial neoplastic lesions in the GI tract. EMR carries lower morbidity and mortality compared to surgery.
    Other Names:
  • EMR, Endoscopic resection
  • Active Comparator: Monopolar Knife

    ESD procedure performed with monopolar knives.

    Procedure: Endoscopic Submucosal Dissection
    Endoscopic submucosal dissection (ESD) is a novel technique for the removal of advanced colonic polyps with high-risk features. ESD is minimally invasive and allows the removal of colonic adenomatous polyp without resorting to surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.
    Other Names:
  • ESD
  • Procedure: Endoscopic Mucosal Resection
    Endoscopic mucosal resection (EMR) is a conventional endoscopic technique commonly used for the resection of superficial neoplastic lesions in the GI tract. EMR carries lower morbidity and mortality compared to surgery.
    Other Names:
  • EMR, Endoscopic resection
  • Outcome Measures

    Primary Outcome Measures

    1. Procedure time [Day 1]

      The speed of endoscopic submucosal dissection as calculated by cm2/hour

    Secondary Outcome Measures

    1. Technical success rate [Day 1, 4 weeks]

      En-bloc, R0 and curative resection rates for each knife

    2. Procedural adverse event [Day 1]

      Adverse events during the procedure: hemorrhage, perforation, etc.

    3. Immediate post-procedural adverse event [Up to 24 hours]

      Abdominal pain after the procedure using Visual Analogue Scale from 1 to 10

    4. Delayed post-procedural adverse event [4 weeks]

      Post polypectomy syndrome in both groups up to one month after the procedure

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Patient is ≥ 18 years old

    2. Patient is capable of providing informed consent

    3. Patient is referred for ESD procedure of gastrointestinal neoplastic lesions

    Exclusion Criteria:
    1. Patient is < 18 years old

    2. Patient refused and/or unable to provide consent

    3. Patient is a pregnant woman

    4. Patients with lesions removed with other techniques besides ESD or a modified ESD technique (i.e., EMR or TEM) as defined in the Japan Gastroenterological Endoscopy Society (JGES) guidelines for endoscopic resection of lesions.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Baylor College of Medicine Houston Texas United States 77030
    2 Baylor St. Lukes Medical Center (BSLMC) Houston Texas United States 77030

    Sponsors and Collaborators

    • Baylor College of Medicine

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Mohamed Othman, M.D. Director of Advanced Endoscopy Assistant Professor of Medicine - Gastroenterology Section, Baylor College of Medicine
    ClinicalTrials.gov Identifier:
    NCT04919824
    Other Study ID Numbers:
    • H-49483
    First Posted:
    Jun 9, 2021
    Last Update Posted:
    Mar 25, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Mohamed Othman, M.D. Director of Advanced Endoscopy Assistant Professor of Medicine - Gastroenterology Section, Baylor College of Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 25, 2022